You can be the difference.
The EFEPA is here to keep you up to date on legislative efforts that have a potential impact on the lives of those with epilepsy. You can help us create a safer and more understanding community by taking action and contacting your representatives if you feel strongly about an issue. Make your voice heard.
Congress has reintroduced the Improving Regulatory Transparency for New Medical Therapies Act in both the House of Representatives (H.R. 639) and the Senate (S. 481) which would improve the transparency and consistency of the Drug Enforcement Agency (DEA) review of new Food and Drug Administration (FDA) approved medications and bring these medications to patients faster.If you support improving the process that allows patients to take their medication, contact your representative today.
The Compassionate Access, Research Expansion and Respect States (CARERS) Act (S. 683 and H.R. 1538) has been introduced in Congress. The CARERS Act would move cannabis to Schedule II and to remove cannabidiol (CBD) from the Controlled Substances Act while also facilitating research on cannabis and CBD. Because CBD is currently categorized under Schedule I, which is the most stringent category, it is difficult for researchers to conduct studies with. If you support research into medical marijuana so that we can better understand it’s potential as a treatment for seizures, click here to ask your representative in Congress to support the CARERS Act.
Check back often to see our current legislative and advocacy priorities!